Evidence map›Paper›PMID 36660381›Full record

ArticleSisli Etfal Hastanesi tip bulteni2022

Neuropsychiatric Effects of COVID-19 Pandemic on Alzheimer's Disease: A Comparative Study of Total and Partial Lockdown.

Nilgun Cinar, Sevki Sahin, Sibel Karsidag, Fenise Selın Karali, Miruna Florentina Ates, Ozge Gonul, Tugba Okluoglu, Fettah Eren, Nazli Gamze Bulbul, Dilek Yilmaz Okuyan and 9 more

Abstract read
In one paragraph

Article in Sisli Etfal Hastanesi tip bulteni, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Nilgun CinarDepartment of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye.
Sevki SahinDepartment of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye.
Sibel KarsidagDepartment of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye.
Fenise Selın KaraliDepartment of Speech and Language Therapy, Biruni University, Faculty of Health Sciences, Istanbul, Türkiye.
Miruna Florentina AtesDepartment of Neurology, Maltepe University, Faculty of Medicine, Istanbul, Türkiye.
Ozge GonulDepartment of Neurology, University of Health Sciences, Sancaktepe Research and Training Hospital, Istanbul, Türkiye.
Tugba OkluogluDepartment of Neurology, Health Sciences University, Istanbul Education Research Hospital, Istanbul, Türkiye.
Fettah ErenDepartment of Neurology, Selcuk University, Faculty of Medicine, Konya, Türkiye.
Nazli Gamze BulbulDepartment of Neurology, University of Health Science, Hamidiye Faculty of Medicine, Sultan Abdulhamid Han Research and Training Hospital, Istanbul, Türkiye.
Dilek Yilmaz OkuyanDepartment of Neurology, Konya Numune State Hospital, Konya, Türkiye.
Ozlem TotukDepartment of Neurology, University of Health Sciences, Sancaktepe Research and Training Hospital, Istanbul, Türkiye.
Esra Aciman DemirelDepartment of Neurology, Bülent Ecevit University Faculty of Medicine, Zonguldak, Türkiye.
Meltem Karacan GolenDepartment of Neurology, Konya Numune State Hospital, Konya, Türkiye.
Zerrin YildirimDepartment of Neurology, University of Health Science, Bağcılar Research and Training Hospital, Istanbul, Türkiye.
Hamdi ErhanAlzheimers Special Care Center, Mersin, Turkey.
Busra Sumeyye Arica PolatDepartment of Neurology, University of Health Science, Gülhane School of Medicine, Research and Training Hospital, Istanbul, Türkiye.
Nesrin ErginDepartment of Neurology, Pamukkale University, Medical Faculty, Denizli, Türkiye.
Esma Kobak TurDepartment of Neurology, University of Health Science, Fatih Sultan Mehmet Research and Training Hospital, Istanbul, Türkiye.
Ozlem AkdoganDepartment of Neurology, Health Sciences University, Istanbul Education Research Hospital, Istanbul, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Coronavirus disease 2019 (COVID-19)-related lockdown may have a negative effect on the neuropsychiatric status of Alzheimer's disease (AD) cases. In this study, it was aimed to find future implications by evaluating the neuropsychiatric conditions of AD cases during total and partial lockdown periods. Methods: It is a prospective, cross-sectional, and multicenter study that includes AD cases which have been followed for at least 1 year by outpatient clinics from different regions of Turkey. Sociodemographic data, comorbidities, mobility, existence of social interactions, clinical dementia rating (CDR) scale, and neuropsychiatric inventory (NPI) for total and partial lockdown were questioned by the caregivers with the help of case files of the patients. Results: A total of 302 AD cases were enrolled to the study (mean age: 78±8 years, mean duration of education: 5.8±9 years). The total comorbidity ratio was found to be 84%, with the most frequent comorbidity being hypertension. The mean NPI score was 22.9±21 in total lockdown and 17.7±15 in partial lockdown, which is statistically significantly different. When lockdown periods were compared with the total scores of NPI scores according to gender, existence of social interactions, mobility, and comorbidities were found higher in the total lockdown than the partial lockdown. When switching from total lockdown to partial lockdown, the presence of comorbidities, mobility, and CDR were found to be factors that had a significant effect on NPI scores. In regression analysis, CDR score was found as the most effective parameter on the neuropsychiatric status of AD cases for both lockdown periods. Conclusion: When lockdown-related restrictions were reduced, the neuropsychological conditions of AD cases were significantly improved. Lockdown rules should be considered with these data in mind.

Indexed as

Alzheimer’s diseaseCoronavirusLockdownNeuropsychiatric statusPandemic

Identifiers

PMID36660381
PMCPMC9833339

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.